Daily News & Analysis: Columns by Pillman http://www.dnaindia.com/ dnaindia.com delivers news and information on the latest top stories, sport, entertainment, business, technology, Mumbai, India, world and more. en-us COPYRIGHT @ 2012 DILIGENT MEDIA CORPORATION LTD. ALL RIGHTS RESERVED XML::RSS Fri, 25 May 2012 16:08:11 GMT Fri, 25 May 2012 16:08:11 GMT http://www.dnaindia.com/syndication/ 10 http://www.dnaindia.com/images/logo_dna_rss.gif Daily News & Analysis: News http://www.dnaindia.com/ 31 88 dnaindia.com delivers news and information on the latest top stories, sport, entertainment, politics, India, World and more. Big Pharma can gain from tango with small fry http://www.dnaindia.com/analysis/column_big-pharma-can-gain-from-tango-with-small-fry_1636406 http://www.dnaindia.com/analysis/column_big-pharma-can-gain-from-tango-with-small-fry_1636406 India’s largest pharmaceutical industry body, the Indian Drug Manufacturers Association, presents a picture of vivid contrasts. Thu, 12 Jan 2012 04:30:00 GMT Clinical trials in India — a delicate line to tread http://www.dnaindia.com/analysis/comment_clinical-trials-in-india-a-delicate-line-to-tread_1633621 http://www.dnaindia.com/analysis/comment_clinical-trials-in-india-a-delicate-line-to-tread_1633621 What started as a rare reporting subject only a few years ago has become a frequent fixture for newspapers and magazines — ethics in clinical trials in India. Thu, 05 Jan 2012 02:30:00 GMT Comment: As pharma buyouts taper, focus shifts to smaller firms http://www.dnaindia.com/analysis/comment_comment-as-pharma-buyouts-taper-focus-shifts-to-smaller-firms_1627885 http://www.dnaindia.com/analysis/comment_comment-as-pharma-buyouts-taper-focus-shifts-to-smaller-firms_1627885 While cross-border deals did not completely subside in the last one year, a long pause is becoming apparent. Tue, 20 Dec 2011 03:45:00 GMT Affordable medicines will take more than price controls http://www.dnaindia.com/money/column_affordable-medicines-will-take-more-than-price-controls_1625007 http://www.dnaindia.com/money/column_affordable-medicines-will-take-more-than-price-controls_1625007 The draft National Pharmaceutical Pricing Policy floated in October by the Department of Pharmaceuticals inviting feedback from stakeholders charts out significant changes Tue, 13 Dec 2011 03:03:00 GMT Make no mistake, multinational drugmakers are very alive to markets such as India http://www.dnaindia.com/money/column_make-no-mistake-multinational-drugmakers-are-very-alive-to-markets-such-as-india_1429683 http://www.dnaindia.com/money/column_make-no-mistake-multinational-drugmakers-are-very-alive-to-markets-such-as-india_1429683 Department of Industrial Policy and Promotion’s apprehension that these companies will ignore local needs and focus only on exports is unfounded. Fri, 27 Aug 2010 20:53:00 GMT Genzyme is just the booster that Sanofi Aventis needs now http://www.dnaindia.com/money/column_genzyme-is-just-the-booster-that-sanofi-aventis-needs-now_1418959 http://www.dnaindia.com/money/column_genzyme-is-just-the-booster-that-sanofi-aventis-needs-now_1418959 Orphan-drug maker, with a strong pipeline and sales of $4.5 billion, will be a prize catch Wed, 04 Aug 2010 21:44:00 GMT Government alone can’t fight cancer, diabetes and strokes http://www.dnaindia.com/money/column_government-alone-cant-fight-cancer-diabetes-and-strokes_1413335 http://www.dnaindia.com/money/column_government-alone-cant-fight-cancer-diabetes-and-strokes_1413335 There should be all-round effort and companies should think beyond the bottomline. Thu, 22 Jul 2010 20:49:00 GMT Despite FDA vote, the word’s caution on Avandia http://www.dnaindia.com/money/column_despite-fda-vote-the-words-caution-on-avandia_1410814 http://www.dnaindia.com/money/column_despite-fda-vote-the-words-caution-on-avandia_1410814 It’s important to put the safety of the patients before any opinion is shared arbitrarily. Fri, 16 Jul 2010 21:42:00 GMT Move to better access to drugs a welcome change http://www.dnaindia.com/money/column_move-to-better-access-to-drugs-a-welcome-change_1404517 http://www.dnaindia.com/money/column_move-to-better-access-to-drugs-a-welcome-change_1404517 Study shows greater willingness among companies to open up Fri, 02 Jul 2010 17:29:08 GMT Stage set for bigger biotechnology play by local companies http://www.dnaindia.com/money/column_stage-set-for-bigger-biotechnology-play-by-local-companies_1397865 http://www.dnaindia.com/money/column_stage-set-for-bigger-biotechnology-play-by-local-companies_1397865 If they surmount the development and launch hiccups, it could well be generics redux. Thu, 17 Jun 2010 21:16:00 GMT